PubMed:33181156
Annnotations
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 551-557 | Body_part | denotes | kidney | http://purl.obolibrary.org/obo/UBERON_0002113 |
T2 | 1094-1100 | Body_part | denotes | kidney | http://purl.obolibrary.org/obo/UBERON_0002113 |
T3 | 1156-1162 | Body_part | denotes | kidney | http://purl.obolibrary.org/obo/UBERON_0002113 |
T4 | 1378-1384 | Body_part | denotes | kidney | http://purl.obolibrary.org/obo/UBERON_0002113 |
T5 | 1471-1476 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
T6 | 1587-1593 | Body_part | denotes | kidney | http://purl.obolibrary.org/obo/UBERON_0002113 |
T7 | 1614-1620 | Body_part | denotes | kidney | http://purl.obolibrary.org/obo/UBERON_0002113 |
T8 | 1874-1880 | Body_part | denotes | kidney | http://purl.obolibrary.org/obo/UBERON_0002113 |
T9 | 2062-2067 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 551-557 | Body_part | denotes | kidney | http://purl.org/sig/ont/fma/fma7203 |
T2 | 1094-1100 | Body_part | denotes | kidney | http://purl.org/sig/ont/fma/fma7203 |
T3 | 1156-1162 | Body_part | denotes | kidney | http://purl.org/sig/ont/fma/fma7203 |
T4 | 1378-1384 | Body_part | denotes | kidney | http://purl.org/sig/ont/fma/fma7203 |
T5 | 1471-1476 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
T6 | 1587-1593 | Body_part | denotes | kidney | http://purl.org/sig/ont/fma/fma7203 |
T7 | 1614-1620 | Body_part | denotes | kidney | http://purl.org/sig/ont/fma/fma7203 |
T8 | 1874-1880 | Body_part | denotes | kidney | http://purl.org/sig/ont/fma/fma7203 |
T9 | 2062-2067 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 22-24 | Disease | denotes | GN | http://purl.obolibrary.org/obo/MONDO_0005033 |
T2 | 65-73 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T3 | 78-96 | Disease | denotes | glomerular disease | http://purl.obolibrary.org/obo/MONDO_0019722 |
T4 | 138-146 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T5 | 149-158 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T6 | 195-213 | Disease | denotes | glomerulonephritis | http://purl.obolibrary.org/obo/MONDO_0002462 |
T7 | 341-350 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T8 | 354-372 | Disease | denotes | glomerulonephritis | http://purl.obolibrary.org/obo/MONDO_0002462 |
T9 | 379-381 | Disease | denotes | GN | http://purl.obolibrary.org/obo/MONDO_0005033 |
T10 | 416-434 | Disease | denotes | glomerulonephritis | http://purl.obolibrary.org/obo/MONDO_0002462 |
T11 | 439-447 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T12 | 521-539 | Disease | denotes | glomerulonephritis | http://purl.obolibrary.org/obo/MONDO_0002462 |
T13 | 610-619 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T14 | 730-738 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T15 | 836-854 | Disease | denotes | glomerulonephritis | http://purl.obolibrary.org/obo/MONDO_0002462 |
T16 | 879-888 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T17 | 930-948 | Disease | denotes | glomerulonephritis | http://purl.obolibrary.org/obo/MONDO_0002462 |
T18 | 1003-1021 | Disease | denotes | glomerulonephritis | http://purl.obolibrary.org/obo/MONDO_0002462 |
T19 | 1088-1107 | Disease | denotes | acute kidney injury | http://purl.obolibrary.org/obo/MONDO_0002492 |
T20 | 1101-1107 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T21 | 1372-1391 | Disease | denotes | acute kidney injury | http://purl.obolibrary.org/obo/MONDO_0002492 |
T22 | 1385-1391 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T23 | 1399-1417 | Disease | denotes | glomerulonephritis | http://purl.obolibrary.org/obo/MONDO_0002462 |
T24 | 1445-1463 | Disease | denotes | glomerulonephritis | http://purl.obolibrary.org/obo/MONDO_0002462 |
T25 | 1525-1543 | Disease | denotes | glomerular disease | http://purl.obolibrary.org/obo/MONDO_0019722 |
T26 | 1581-1600 | Disease | denotes | acute kidney injury | http://purl.obolibrary.org/obo/MONDO_0002492 |
T27 | 1594-1600 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T28 | 1708-1726 | Disease | denotes | glomerulonephritis | http://purl.obolibrary.org/obo/MONDO_0002462 |
T29 | 1734-1752 | Disease | denotes | glomerulonephritis | http://purl.obolibrary.org/obo/MONDO_0002462 |
T30 | 1771-1798 | Disease | denotes | systemic autoimmune disease | http://purl.obolibrary.org/obo/MONDO_0015939 |
T31 | 1780-1798 | Disease | denotes | autoimmune disease | http://purl.obolibrary.org/obo/MONDO_0007179 |
T32 | 1800-1805 | Disease | denotes | lupus | http://purl.obolibrary.org/obo/MONDO_0004670 |
T33 | 1809-1819 | Disease | denotes | vasculitis | http://purl.obolibrary.org/obo/MONDO_0018882 |
T34 | 1868-1887 | Disease | denotes | acute kidney injury | http://purl.obolibrary.org/obo/MONDO_0002492 |
T35 | 1881-1887 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T36 | 1927-1945 | Disease | denotes | glomerulonephritis | http://purl.obolibrary.org/obo/MONDO_0002462 |
T37 | 1961-1979 | Disease | denotes | glomerulonephritis | http://purl.obolibrary.org/obo/MONDO_0002462 |
T38 | 1984-1992 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 551-557 | http://purl.obolibrary.org/obo/UBERON_0002113 | denotes | kidney |
T2 | 551-557 | http://www.ebi.ac.uk/efo/EFO_0000927 | denotes | kidney |
T3 | 551-557 | http://www.ebi.ac.uk/efo/EFO_0000929 | denotes | kidney |
T4 | 1094-1100 | http://purl.obolibrary.org/obo/UBERON_0002113 | denotes | kidney |
T5 | 1094-1100 | http://www.ebi.ac.uk/efo/EFO_0000927 | denotes | kidney |
T6 | 1094-1100 | http://www.ebi.ac.uk/efo/EFO_0000929 | denotes | kidney |
T7 | 1156-1162 | http://purl.obolibrary.org/obo/UBERON_0002113 | denotes | kidney |
T8 | 1156-1162 | http://www.ebi.ac.uk/efo/EFO_0000927 | denotes | kidney |
T9 | 1156-1162 | http://www.ebi.ac.uk/efo/EFO_0000929 | denotes | kidney |
T10 | 1378-1384 | http://purl.obolibrary.org/obo/UBERON_0002113 | denotes | kidney |
T11 | 1378-1384 | http://www.ebi.ac.uk/efo/EFO_0000927 | denotes | kidney |
T12 | 1378-1384 | http://www.ebi.ac.uk/efo/EFO_0000929 | denotes | kidney |
T13 | 1587-1593 | http://purl.obolibrary.org/obo/UBERON_0002113 | denotes | kidney |
T14 | 1587-1593 | http://www.ebi.ac.uk/efo/EFO_0000927 | denotes | kidney |
T15 | 1587-1593 | http://www.ebi.ac.uk/efo/EFO_0000929 | denotes | kidney |
T16 | 1614-1620 | http://purl.obolibrary.org/obo/UBERON_0002113 | denotes | kidney |
T17 | 1614-1620 | http://www.ebi.ac.uk/efo/EFO_0000927 | denotes | kidney |
T18 | 1614-1620 | http://www.ebi.ac.uk/efo/EFO_0000929 | denotes | kidney |
T19 | 1769-1770 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T20 | 1874-1880 | http://purl.obolibrary.org/obo/UBERON_0002113 | denotes | kidney |
T21 | 1874-1880 | http://www.ebi.ac.uk/efo/EFO_0000927 | denotes | kidney |
T22 | 1874-1880 | http://www.ebi.ac.uk/efo/EFO_0000929 | denotes | kidney |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 22-24 | Chemical | denotes | GN | http://purl.obolibrary.org/obo/CHEBI_73888 |
T2 | 379-381 | Chemical | denotes | GN | http://purl.obolibrary.org/obo/CHEBI_73888 |
T3 | 1276-1287 | Chemical | denotes | angiotensin | http://purl.obolibrary.org/obo/CHEBI_48433 |
T4 | 1288-1299 | Chemical | denotes | aldosterone | http://purl.obolibrary.org/obo/CHEBI_27584|http://purl.obolibrary.org/obo/CHEBI_30834 |
T6 | 1307-1317 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
3 | 51-59 | Species | denotes | patients | Tax:9606 |
4 | 65-73 | Disease | denotes | COVID-19 | MESH:C000657245 |
5 | 78-96 | Disease | denotes | glomerular disease | MESH:D007674 |
44 | 138-158 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 |
45 | 195-213 | Disease | denotes | glomerulonephritis | MESH:D005921 |
46 | 335-350 | Disease | denotes | COVID infection | MESH:C000657245 |
47 | 354-372 | Disease | denotes | glomerulonephritis | MESH:D005921 |
48 | 402-410 | Species | denotes | patients | Tax:9606 |
49 | 416-434 | Disease | denotes | glomerulonephritis | MESH:D005921 |
50 | 439-447 | Disease | denotes | COVID-19 | MESH:C000657245 |
51 | 521-539 | Disease | denotes | glomerulonephritis | MESH:D005921 |
52 | 610-619 | Disease | denotes | infection | MESH:D007239 |
53 | 730-738 | Disease | denotes | COVID-19 | MESH:C000657245 |
54 | 771-776 | Disease | denotes | COVID | MESH:C000657245 |
55 | 836-854 | Disease | denotes | glomerulonephritis | MESH:D005921 |
56 | 879-888 | Disease | denotes | infection | MESH:D007239 |
57 | 916-924 | Species | denotes | patients | Tax:9606 |
58 | 930-948 | Disease | denotes | glomerulonephritis | MESH:D005921 |
59 | 989-997 | Species | denotes | Patients | Tax:9606 |
60 | 1003-1021 | Disease | denotes | glomerulonephritis | MESH:D005921 |
61 | 1047-1056 | Disease | denotes | mortality | MESH:D003643 |
62 | 1088-1107 | Disease | denotes | acute kidney injury | MESH:D058186 |
63 | 1288-1299 | Chemical | denotes | aldosterone | MESH:D000450 |
64 | 1363-1368 | Disease | denotes | death | MESH:D003643 |
65 | 1372-1391 | Disease | denotes | acute kidney injury | MESH:D058186 |
66 | 1399-1417 | Disease | denotes | glomerulonephritis | MESH:D005921 |
67 | 1445-1463 | Disease | denotes | glomerulonephritis | MESH:D005921 |
68 | 1477-1484 | Gene | denotes | albumin | Gene:213 |
69 | 1525-1543 | Disease | denotes | glomerular disease | MESH:D007674 |
70 | 1581-1600 | Disease | denotes | acute kidney injury | MESH:D058186 |
71 | 1686-1694 | Species | denotes | patients | Tax:9606 |
72 | 1708-1752 | Disease | denotes | glomerulonephritis versus glomerulonephritis | MESH:D005921 |
73 | 1771-1798 | Disease | denotes | systemic autoimmune disease | MESH:D020274 |
74 | 1800-1819 | Disease | denotes | lupus or vasculitis | MESH:D020945 |
75 | 1846-1855 | Disease | denotes | mortality | MESH:D003643 |
76 | 1868-1887 | Disease | denotes | acute kidney injury | MESH:D058186 |
77 | 1927-1945 | Disease | denotes | glomerulonephritis | MESH:D005921 |
78 | 1947-1955 | Species | denotes | patients | Tax:9606 |
79 | 1961-1979 | Disease | denotes | glomerulonephritis | MESH:D005921 |
80 | 1984-1992 | Disease | denotes | COVID-19 | MESH:C000657245 |
81 | 2068-2075 | Gene | denotes | albumin | Gene:213 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-122 | Sentence | denotes | Results from the IRoc-GN international registry of patients with COVID-19 and glomerular disease suggest close monitoring. |
T2 | 123-282 | Sentence | denotes | The effects of SARS-CoV-2 infection on individuals with immune-mediated glomerulonephritis, who are often undergoing immunosuppressive treatments, are unknown. |
T3 | 283-496 | Sentence | denotes | Therefore, we created the International Registry of COVID infection in glomerulonephritis (IRoc-GN), and identified 40 patients with glomerulonephritis and COVID-19 followed in centers in North America and Europe. |
T4 | 497-739 | Sentence | denotes | Detailed information on glomerulonephritis diagnosis, kidney parameters, and baseline immunosuppression prior to infection were recorded, as well as clinical presentation, laboratory values, treatment, complications, and outcomes of COVID-19. |
T5 | 740-889 | Sentence | denotes | This cohort was compared to 80 COVID-positive control cases from the general population without glomerulonephritis matched for the time of infection. |
T6 | 890-988 | Sentence | denotes | The majority (70%) of the patients with glomerulonephritis and all the controls were hospitalized. |
T7 | 989-1238 | Sentence | denotes | Patients with glomerulonephritis had significantly higher mortality (15% vs. 5%, respectively) and acute kidney injury (39% vs. 14%) than controls, while the need for kidney replacement therapy was not statistically different between the two groups. |
T8 | 1239-1425 | Sentence | denotes | Receiving immunosuppression or renin-angiotensin-aldosterone system inhibitors at presentation did not increase the risk of death or acute kidney injury in the glomerulonephritis cohort. |
T9 | 1426-1641 | Sentence | denotes | In the cohort with glomerulonephritis, lower serum albumin at presentation and shorter duration of glomerular disease were associated with greater risk of acute kidney injury and need for kidney replacement therapy. |
T10 | 1642-1821 | Sentence | denotes | No differences in outcomes occurred between patients with primary glomerulonephritis versus glomerulonephritis associated with a systemic autoimmune disease (lupus or vasculitis). |
T11 | 1822-2083 | Sentence | denotes | Thus, due to the higher mortality and risk of acute kidney injury than in the general population without glomerulonephritis, patients with glomerulonephritis and COVID-19 should be carefully monitored, especially when they present with low serum albumin levels. |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 195-213 | Phenotype | denotes | glomerulonephritis | http://purl.obolibrary.org/obo/HP_0000099 |
T2 | 354-372 | Phenotype | denotes | glomerulonephritis | http://purl.obolibrary.org/obo/HP_0000099 |
T3 | 416-434 | Phenotype | denotes | glomerulonephritis | http://purl.obolibrary.org/obo/HP_0000099 |
T4 | 521-539 | Phenotype | denotes | glomerulonephritis | http://purl.obolibrary.org/obo/HP_0000099 |
T5 | 836-854 | Phenotype | denotes | glomerulonephritis | http://purl.obolibrary.org/obo/HP_0000099 |
T6 | 930-948 | Phenotype | denotes | glomerulonephritis | http://purl.obolibrary.org/obo/HP_0000099 |
T7 | 1003-1021 | Phenotype | denotes | glomerulonephritis | http://purl.obolibrary.org/obo/HP_0000099 |
T8 | 1088-1107 | Phenotype | denotes | acute kidney injury | http://purl.obolibrary.org/obo/HP_0001919 |
T9 | 1372-1391 | Phenotype | denotes | acute kidney injury | http://purl.obolibrary.org/obo/HP_0001919 |
T10 | 1399-1417 | Phenotype | denotes | glomerulonephritis | http://purl.obolibrary.org/obo/HP_0000099 |
T11 | 1445-1463 | Phenotype | denotes | glomerulonephritis | http://purl.obolibrary.org/obo/HP_0000099 |
T12 | 1581-1600 | Phenotype | denotes | acute kidney injury | http://purl.obolibrary.org/obo/HP_0001919 |
T13 | 1708-1726 | Phenotype | denotes | glomerulonephritis | http://purl.obolibrary.org/obo/HP_0000099 |
T14 | 1734-1752 | Phenotype | denotes | glomerulonephritis | http://purl.obolibrary.org/obo/HP_0000099 |
T15 | 1780-1798 | Phenotype | denotes | autoimmune disease | http://purl.obolibrary.org/obo/HP_0002960 |
T16 | 1809-1819 | Phenotype | denotes | vasculitis | http://purl.obolibrary.org/obo/HP_0002633 |
T17 | 1868-1887 | Phenotype | denotes | acute kidney injury | http://purl.obolibrary.org/obo/HP_0001919 |
T18 | 1927-1945 | Phenotype | denotes | glomerulonephritis | http://purl.obolibrary.org/obo/HP_0000099 |
T19 | 1961-1979 | Phenotype | denotes | glomerulonephritis | http://purl.obolibrary.org/obo/HP_0000099 |
Inflammaging
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-122 | Sentence | denotes | Results from the IRoc-GN international registry of patients with COVID-19 and glomerular disease suggest close monitoring. |
T2 | 123-282 | Sentence | denotes | The effects of SARS-CoV-2 infection on individuals with immune-mediated glomerulonephritis, who are often undergoing immunosuppressive treatments, are unknown. |
T3 | 283-496 | Sentence | denotes | Therefore, we created the International Registry of COVID infection in glomerulonephritis (IRoc-GN), and identified 40 patients with glomerulonephritis and COVID-19 followed in centers in North America and Europe. |
T4 | 497-739 | Sentence | denotes | Detailed information on glomerulonephritis diagnosis, kidney parameters, and baseline immunosuppression prior to infection were recorded, as well as clinical presentation, laboratory values, treatment, complications, and outcomes of COVID-19. |
T5 | 740-889 | Sentence | denotes | This cohort was compared to 80 COVID-positive control cases from the general population without glomerulonephritis matched for the time of infection. |
T6 | 890-988 | Sentence | denotes | The majority (70%) of the patients with glomerulonephritis and all the controls were hospitalized. |
T7 | 989-1238 | Sentence | denotes | Patients with glomerulonephritis had significantly higher mortality (15% vs. 5%, respectively) and acute kidney injury (39% vs. 14%) than controls, while the need for kidney replacement therapy was not statistically different between the two groups. |
T8 | 1239-1425 | Sentence | denotes | Receiving immunosuppression or renin-angiotensin-aldosterone system inhibitors at presentation did not increase the risk of death or acute kidney injury in the glomerulonephritis cohort. |
T9 | 1426-1641 | Sentence | denotes | In the cohort with glomerulonephritis, lower serum albumin at presentation and shorter duration of glomerular disease were associated with greater risk of acute kidney injury and need for kidney replacement therapy. |
T10 | 1642-1821 | Sentence | denotes | No differences in outcomes occurred between patients with primary glomerulonephritis versus glomerulonephritis associated with a systemic autoimmune disease (lupus or vasculitis). |
T11 | 1822-2083 | Sentence | denotes | Thus, due to the higher mortality and risk of acute kidney injury than in the general population without glomerulonephritis, patients with glomerulonephritis and COVID-19 should be carefully monitored, especially when they present with low serum albumin levels. |
T1 | 0-122 | Sentence | denotes | Results from the IRoc-GN international registry of patients with COVID-19 and glomerular disease suggest close monitoring. |
T2 | 123-282 | Sentence | denotes | The effects of SARS-CoV-2 infection on individuals with immune-mediated glomerulonephritis, who are often undergoing immunosuppressive treatments, are unknown. |
T3 | 283-496 | Sentence | denotes | Therefore, we created the International Registry of COVID infection in glomerulonephritis (IRoc-GN), and identified 40 patients with glomerulonephritis and COVID-19 followed in centers in North America and Europe. |
T4 | 497-739 | Sentence | denotes | Detailed information on glomerulonephritis diagnosis, kidney parameters, and baseline immunosuppression prior to infection were recorded, as well as clinical presentation, laboratory values, treatment, complications, and outcomes of COVID-19. |
T5 | 740-889 | Sentence | denotes | This cohort was compared to 80 COVID-positive control cases from the general population without glomerulonephritis matched for the time of infection. |
T6 | 890-988 | Sentence | denotes | The majority (70%) of the patients with glomerulonephritis and all the controls were hospitalized. |
T7 | 989-1238 | Sentence | denotes | Patients with glomerulonephritis had significantly higher mortality (15% vs. 5%, respectively) and acute kidney injury (39% vs. 14%) than controls, while the need for kidney replacement therapy was not statistically different between the two groups. |
T8 | 1239-1425 | Sentence | denotes | Receiving immunosuppression or renin-angiotensin-aldosterone system inhibitors at presentation did not increase the risk of death or acute kidney injury in the glomerulonephritis cohort. |
T9 | 1426-1641 | Sentence | denotes | In the cohort with glomerulonephritis, lower serum albumin at presentation and shorter duration of glomerular disease were associated with greater risk of acute kidney injury and need for kidney replacement therapy. |
T10 | 1642-1821 | Sentence | denotes | No differences in outcomes occurred between patients with primary glomerulonephritis versus glomerulonephritis associated with a systemic autoimmune disease (lupus or vasculitis). |
T11 | 1822-2083 | Sentence | denotes | Thus, due to the higher mortality and risk of acute kidney injury than in the general population without glomerulonephritis, patients with glomerulonephritis and COVID-19 should be carefully monitored, especially when they present with low serum albumin levels. |